Publications by authors named "Johan Lennerstrand"

Claim this Profile
D
Dynamics of SARS-CoV-2 variants and mutations in Central Sweden between 2023 and 2024 and their potential implications on monoclonal antibodies pemivibart and sipavibart as PrEP in the region.
Jonathan Haars, Frans Wallin, Karin Elfving, Anna-Karin Jonsson, Patrik Ellström, Johan Lennerstrand

Infect Dis (Lond)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of novel and potent inhibitors of SARS-CoV-2 main protease from DNA-encoded chemical libraries.
Dario Akaberi, Monireh Pourghasemi Lati, Janina Krambrich, Julia Berger, Grace Neilsen, Johan Lennerstrand

Antimicrob Agents Chemother· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From SARS-CoV-2 to Global Preparedness: A Graphical Interface for Standardised High-Throughput Bioinformatics Analysis in Pandemic Scenarios and Surveillance of Drug Resistance.
Tomas Cumlin, Ida Karlsson, Jonathan Haars, Maria Rosengren, Johan Lennerstrand

Int J Mol Sci· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of SARS-CoV-2 Omicron Sublineages and Spike Protein Mutations Conferring Resistance against Monoclonal Antibodies in a Swedish Cohort during 2022-2023.
Jonathan Haars, Navaneethan Palanisamy, Frans Wallin, Paula Mölling, Johan Lindh, Johan Lennerstrand

Microorganisms· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 variants of concern and spike protein mutational dynamics in a Swedish cohort during 2021, studied by Nanopore sequencing.
Steinar Mannsverk, Julia Bergholm, Navaneethan Palanisamy, Patrik Ellström, René Kaden, Johan Lennerstrand

Virol J· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals.
Anita Y M Howe, Chaturaka Rodrigo, Evan B Cunningham, Mark W Douglas, Julia Dietz, Johan Lennerstrand

JHEP Rep· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultralarge Virtual Screening Identifies SARS-CoV-2 Main Protease Inhibitors with Broad-Spectrum Activity against Coronaviruses.
Andreas Luttens, Hjalmar Gullberg, Eldar Abdurakhmanov, Duy Duc Vo, Dario Akaberi, Johan Lennerstrand

J Am Chem Soc· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[How did Omicron evolve and why does this SARS-CoV-2 variant spread so fast?].
Johan Lennerstrand, Lennart Svensson, Åke Lundkvist

Lakartidningen· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global Prevalence of Adaptive and Prolonged Infections' Mutations in the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein.
Johan Lennerstrand, Navaneethan Palanisamy

Viruses· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SHARED: An International Collaboration to Unravel Hepatitis C Resistance.
Anita Y M Howe, Francesca Ceccherini-Silberstein, Julia Dietz, Stephanie Popping, Jason Grebely, Johan Lennerstrand

Viruses· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the NS2B-NS3 protease of tick-borne encephalitis virus with pan-flaviviral protease inhibitors.
Dario Akaberi, Amanda Båhlström, Praveen K Chinthakindi, Tomas Nyman, Anja Sandström, Johan Lennerstrand

Antiviral Res· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a C2-symmetric diol based human immunodeficiency virus protease inhibitor targeting Zika virus NS2B-NS3 protease.
Dario Akaberi, Praveen K Chinthakindi, Amanda Båhlström, Navaneethan Palanisamy, Anja Sandström, Johan Lennerstrand

J Biomol Struct Dyn· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitigation of the replication of SARS-CoV-2 by nitric oxide in vitro.
Dario Akaberi, Janina Krambrich, Jiaxin Ling, Chen Luni, Göran Hedenstierna, Johan Lennerstrand

Redox Biol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Worldwide prevalence of baseline resistance-associated polymorphisms and resistance mutations in HCV against current direct-acting antivirals.
Navaneethan Palanisamy, Prabhav Kalaghatgi, Dario Akaberi, Åke Lundkvist, Zhi-Wei Chen, Johan Lennerstrand

Antivir Ther· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of the baseline Y93H resistance-associated substitution in HCV genotype 3 for direct-acting antiviral treatment: real-life experience from a multicenter study in Sweden and Norway.
Midori Kjellin, Hege Kileng, Dario Akaberi, Navaneethan Palanisamy, Ann-Sofi Duberg, Johan Lennerstrand

Scand J Gastroenterol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized treatment of hepatitis C genotype 1a in Norway and Sweden 2014-2016: a study of treatment outcome in patients with or without resistance-based DAA-therapy.
Hege Kileng, Midori Kjellin, Dario Akaberi, Assar Bergfors, Ann-Sofi Duberg, Johan Lennerstrand

Scand J Gastroenterol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline dasabuvir resistance in Hepatitis C virus from the genotypes 1, 2 and 3 and modeling of the NS5B-dasabuvir complex by the approach.
Dario Akaberi, Assar Bergfors, Midori Kjellin, Nader Kameli, Louise Lidemalm, Johan Lennerstrand

Infect Ecol Epidemiol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative genome analysis of Alkhumra hemorrhagic fever virus with Kyasanur forest disease and tick-borne encephalitis viruses by the in silico approach.
Navaneethan Palanisamy, Dario Akaberi, Johan Lennerstrand, Åke Lundkvist

Pathog Glob Health· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biophysical Studies on HCV 1a NS3/4A Protease and Its Catalytic Triad in Wild Type and Mutants by the In Silico Approach.
Navaneethan Palanisamy, Johan Lennerstrand

Interdiscip Sci· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of the first-generation HCV-protease inhibitors boceprevir and telaprevir and the relation to baseline NS3 resistance mutations in genotype 1: experience from a small Swedish cohort.
Midori Kjellin, Terése Wesslén, Erik Löfblad, Johan Lennerstrand, Anders Lannergård

Ups J Med Sci· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein backbone flexibility pattern is evolutionarily conserved in the Flaviviridae family: A case of NS3 protease in Flavivirus and Hepacivirus.
Navaneethan Palanisamy, Dario Akaberi, Johan Lennerstrand

Mol Phylogenet Evol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequencing of hepatitis C virus for detection of resistance to direct-acting antiviral therapy: A systematic review.
Sofia R Bartlett, Jason Grebely, Auda A Eltahla, Jacqueline D Reeves, Anita Y M Howe, Johan Lennerstrand

Hepatol Commun· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SYBR Green II Dye-Based Real-Time Assay for Measuring Inhibitor Activity Against HIV-1 Reverse Transcriptase.
Chakradhar Kokkula, Navaneethan Palanisamy, Malin Ericstam, Johan Lennerstrand

Mol Biotechnol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply.
Veronica Miller, Patrick Harrington, Anita Howe, Tara Kieffer, Johan Lennerstrand

Hepatology· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of hepatitis C NS5A resistance associated polymorphisms using ultra deep single molecule real time (SMRT) sequencing.
Assar Bergfors, Daniël Leenheer, Anders Bergqvist, Adam Ameur, Johan Lennerstrand

Antiviral Res· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis